Hrv Global Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.60 M
- Revenue Growth 135.39%
- Profit Growth 591.24%
- Ebitda -31.72%
- Net Worth 200.61%
- Total Assets 202.85%
About Hrv Global Life Sciences
Hrv Global Life Sciences Private Limited (HGLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 June 2015 (Nine years and seven months 28 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajiv Maddula, Suma Chereddi, and Harikiran Chereddi serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100TG2015PTC099220
- Company No.
099220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Hrv Global Life Sciences?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harikiran Chereddi | Managing Director | 01-Jul-2017 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajiv Maddula | Director | 07-Jun-2019 | Current |
Suma Chereddi | Director | 01-Jul-2017 | Current |
Financial Performance of Hrv Global Life Sciences.
Hrv Global Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 135.39% increase. The company also saw a substantial improvement in profitability, with a 591.24% increase in profit. The company's net worth Soared by an impressive increase of 200.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Hrv Global Life Sciences?
In 2021, Hrv Global Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹3.60 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.36 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
23 Mar 2023 | Hdfc Bank Limited | ₹3.60 M | Satisfied |
How Many Employees Work at Hrv Global Life Sciences?
Unlock and access historical data on people associated with Hrv Global Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hrv Global Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hrv Global Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.